InvestorsHub Logo
Followers 7
Posts 161
Boards Moderated 0
Alias Born 10/20/2018

Re: lizzy241 post# 387117

Wednesday, 08/24/2022 7:55:25 AM

Wednesday, August 24, 2022 7:55:25 AM

Post# of 429200
Lizzie, Below is from a conclusion section of the doc. Will see if I can find other interesting tidbits as word translator only allows up to 3900 characters.

Conclusiononstateofsciencepractice Icosapentethylmeetsstateofscienceandpractice in reducing the risk of cardiovascular events in adult statin-treated patients with high cardiovascular risk with elevated triglycerides (at least 1.7 and maximum 5.6 mmol/L) and an established cardiovascular disease or diabetes with at least one cardiovascular risk factor. The Healthcare Institute concludes on the basis of the data that the medicine has added value compared to usual care.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News